 HAMILTON, Bermuda, Aug. 04, 2020 GLOBE NEWSWIRE -- Kiniksa Pharmaceuticals, Ltd. Nasdaq: KNSA announced today that it will present at the 2020 Wedbush PacGrow Healthcare Conference on Tuesday, August 11th, 2020 at 1:10 p.m. Eastern Time. A live webcast of Kiniksas presentation will be accessible through the Investors Media section of the companys website at A replay of the webcast will be available on Kiniksas website for 14 days following the conference.About Kiniksa Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksas clinical-stage product candidates, rilonacept, mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions and offer the potential for differentiation. These pipeline assets are designed to modulate immunological pathways that are implicated across a spectrum of diseases. For more information, please visit Second Counts!TM Kiniksa Investor and Media Contact Mark Ragosa 781 430-8289 